UNH

UnitedHealth Group Incorporated (UNH)

Last Price$467.1(1.7%)
Market Cap$436.0B

UNH Rating

UNH Intrinsic Value

Key Highlights:
As of Mar 03, 2025 UNH Relative Value is $251.5, which is overvalued by 46.2%, compared to current share price of $467.1.
As of Mar 03, 2025 UNH DCF Value is $1,851.9, which is undervalued by 296.5%, compared to current share price of $467.1.
Methodology
Price per share, $
Current share price
467.1
DCF value
1,851.9

UNH Share Price History

1W 1.2%
1M (14.8%)
6M (21.4%)
YTD (12.0%)
1Y (1.6%)
3Y 0.2%
5Y 92.3%
10Y 381.8%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!

UNH Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$436.0B
Shares Outstanding
933M
Employees
400K
Valuation (LTM)
Return on Capital
7.2%
4.8%
28.1%
15.0%
Earnings
Jul 14, 2025
MISS by (0.8%)
BEAT by 1.0%
10 Beat & null Miss

UNH Stock Financials

UNH Income Statement Metrics

Annual
Quarterly
LTM

Revenue

$400.3B +8.9% YoY

Operating Income

$32.3B -0.2% YoY

Net Income

$14.4B -35.6% YoY

UNH Cash Flow Statement Metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$24.2B -16.7% YoY

Capital Expenditure (CAPEX)

($3,499.0M) +3.3% YoY

Free Cash Flow (FCF)

$20.7B -19.4% YoY

UNH Income Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$400.3B 8.9% YoY
$89.4B 2.9% YoY
22.3% margin
Cost of revenue
$310.9B 10.8% YoY
Operating income
$32.3B (0.2%) YoY
8.1% margin
Other: $16.1B
Net interest: $3,906.0M
Operating expenses
$57.1B 4.8% YoY
Pre-tax income
$20.1B (31.1%) YoY
5.0% margin
Net income
$14.4B (35.6%) YoY
3.6% margin
Income tax
$4,829.0M
(24.1%) tax rate
SG&A
$57.1B 4.5% YoY
14.3% of revenue

UNH Balance Sheet Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$298.3B
Current assets ($25.3B, 8.5% of total)
Other current assets
$0.0 (0.0%)
Non-current assets ($273.0B, 91.5% of total)
Other non-current assets
$273.0B (91.5%)
Financial position
$47.0B
$25.3B$72.4B
Cash & Short-term Investments
Total Debt

UNH Stock Ratios

UNH Earnings Surprises

Crunching data... Almost there!

UNH Dividends

UNH Dividend Yield

Crunching data... Almost there!

UNH Dividend Per Share

Competing with UNH

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Quality rating
Intrinsic value
1Y Return
Revenue
Free Cash Flow
Revenue growth
FCF margin
Gross margin
ROIC
Total Debt to Equity
$436.0B
5.9
$1,047.3
124.2% undervalued
(1.6%)
$398.3B
$20.7B
8.4%
5.2%
21.9%
28.1%
1.5%
$90.7B
6.7
$1,001.8
153.3% undervalued
(20.5%)
$176.8B
$4,552.0M
3.2%
2.6%
43.4%
161.3%
4.9%
$87.2B
5.8
$942.9
202.7% undervalued
(6.0%)
$245.3B
$8,957.0M
25.7%
3.7%
48.9%
4.9%
77.5%
$82.3B
5.1
$208.2
220.8% undervalued
(9.3%)
$372.8B
$6,326.0M
4.2%
1.7%
13.8%
3.7%
109.5%
$31.5B
6.1
$797.8
205.0% undervalued
(23.7%)
$117.8B
$2,391.0M
10.7%
2.0%
91.9%
58.6%
71.3%
$29.1B
5.4
$1,406.9
2,301.3% undervalued
(25.2%)
$163.1B
($490.0M)
5.9%
(0.3%)
13.1%
12.0%
69.9%
$17.3B
6.3
$414.9
37.0% undervalued
(21.7%)
$40.6B
$544.0M
19.2%
1.3%
34.7%
33.0%
69.4%
$3,703.3M
6.1
$23.7
57.0% undervalued
(1.7%)
$9,177.6M
$950.3M
56.6%
10.4%
100.0%
(15.2%)
29.5%
$3,104.9M
5.4
$8.2
47.0% overvalued
187.4%
$2,703.6M
($6,648.0K)
48.3%
(0.2%)
33.7%
(41.1%)
7.8%
$1,871.6M
5.2
$2.0
45.3% overvalued
330.8%
$1,370.6M
$128.3M
(32.4%)
9.4%
53.9%
1.2%
0.0%
$65.5M
5.0
$46.2
463.3% undervalued
(85.9%)
$1,616.6M
($2,834.8M)
(71.1%)
(175.4%)
7.8%
(63.3%)
(145.5%)

FAQ

What is UnitedHealth Group Incorporated (UNH) stock rating?

As of today, UnitedHealth Group Incorporated has a stock rating of 6 (out of 10), which is considered Good.

is UnitedHealth Group Incorporated (UNH) a good stock to buy?

As of today, UnitedHealth Group Incorporated has a Good stock rating, which is 124.2% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.